Com-pare2 Flu Relief Tablet
NDC Package 17312-179-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Com-pare2 Flu Relief (anas barbariae) tablets is directions • Suitable for adults and children ages 2 and over. This formulation utilizes a tablet delivery system. Marketed by Trp Company, this product is identified by NDC 17312-179.

Identification & Billing

NDC Package Code
17312-179-30
Package Description
2 BLISTER PACK in 1 BOX / 15 TABLET in 1 BLISTER PACK
Product Code
17312-179
11-Digit Billing Format
17312017930

Clinical Specifications

Proprietary Name
Com-pare2 Flu Relief
Non-Proprietary Name
Anas Barbariae
Substance Name
Cairina Moschata Heart/liver Autolysate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE 200 [hp_C]/1
Usage Information
Directions • Suitable for adults and children ages 2 and over. Children under the age of 2: Consult a physician before use. Dissolve entire tablet under tongue. • Do not chew or swallow whole. • Take 1 tablet every six hours. • Take at least 10 minutes before or at least 10 minutes after eating or drinking. • Homeopathic remedies may not be effective for everyone. Individual results may vary.

Regulatory & Marketing

Labeler Name
Trp Company
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
02-15-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17312-179-30 identifies a specific commercial package of 2 blister pack in 1 box / 15 tablet in 1 blister pack of Com-pare2 Flu Relief, a human over the counter drug labeled by Trp Company. This tablet is formulated for oral use and contains cairina moschata heart/liver autolysate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Trp Company on February 15, 2021. The current certification is valid through December 31, 2026.

How is this Trp Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17312017930. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
17312-179-30
11-Digit CMS (5-4-2)
17312-0179-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.